Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cilostazol efficacy in type 2 diabetes with lower-extremity ischemia assessed by transcutaneous oxygen pressure
ChiCTR-TRC-09000441Phase 4Completed
- Sponsor
- Sun Yat-sen Memorial Hospital
- Start
- Feb 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of cilostazol in lower extremity ischemia (PAD) (2 arms), sponsored by Sun Yat-sen Memorial Hospital. Primary endpoints: Supine transcutaneous oxygen pressure and Improvement of ischemic symptoms of lower extremity. Started Feb 2007; status: completed.
02
Drugs
cilostazol
03
Conditions
lower extremity ischemia (PAD)
Beyond the preview
Go deeper on ChiCTR-TRC-09000441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TRC-09000441.